Open AccessChronic respiratory failure in severe asthma – Questions answered after biological therapy, a clinical case
Author(s) -
Joana Branco,
Filipa Todo Bom,
Sofia Furtado
Publication year - 2021
Publication title -
revista portuguesa de imunoalergologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.13
H-Index - 5
eISSN - 2184-3856
pISSN - 0871-9721
DOI - 10.32932/rpia.2021.09.066
Subject(s) - medicine , asthma , respiratory failure , intensive care medicine , refractory (planetary science) , respiratory system , inflammation , corticosteroid , immunology , physics , astrobiology
Severe asthma is defined as either refractory to traditional therapies or controlled only with therapies that have intolerable side effects. Biological agents are known to offer treatment alternatives to patients with type 2 inflammation severe asthma. We describe the case of a woman with a long history of type 2 inflammation severe asthma, with uncontrolled symptoms and need of systemic corticosteroid therapy as prevailing features, and with respiratory failure that differentiated her from other patients with severe asthma.